Learn more about how we are responding to the coronavirus pandemic in Eswatini.
One-third of adults in Eswatini are HIV positive, which also increases their vulnerability to TB and other infections. In this context, Doctors Without Borders/Médecins Sans Frontières (MSF) continued to assist the Ministry of Health with prevention and care in Shiselweni region in 2018, while handing over some long-term activities to the ministry and partner organizations, such as our project in Manzini region, which began as an emergency intervention in 2010.
Our emphasis in Eswatini is on community-based, patient- centered models of care and what is known as a ‘test and start’ strategy, which involves initiating antiretroviral (ARV) treatment at the time of diagnosis, irrespective of clinical criteria.
We offer community-based testing for HIV and TB, oral HIV self-testing for hard-to-reach groups such as sex workers and men who have sex with men, and pre-exposure prophylaxis (PrEP) for people at increased risk of HIV infection. A total of 5,296 people accessed HIV self-testing and 468 were initiated on PrEP in 2018.
Our teams provide specialized, integrated care for people living with HIV, including second- and third-line ARV therapy for those whose previous treatment has failed to work, and point-of-care screening and treatment for other diseases, such as cervical cancer, drug-resistant TB, and cryptococcal meningitis, which commonly occur in people living with HIV.
In 2018, 1,610 women were screened for cervical cancer, of whom 8 percent tested positive. Of these, 67 percent were treated. We provided prophylactic treatment for cryptococcal meningitis to 26 patients.